The Insides News- The Insides Neo - fistuloclysis, distal feeding, best, alternative to parenteral nutrition, fistula, ostomy, ileostomy, chyme, enteral, oral nutrition, enteromate, intestinal failure, colon cancer, bowel cancer, gut cancer, ostomy appliance, high output, chyme, dehydration, defunctioned, ileus, lars, microbiome, lower interior resection syndrome, incontinent, incontinence, gut health, reversal surgery
The Insides Company LLC Earns Spot in Prestigious CTIP Pediatric Healthcare Innovation Portfolio

The Insides Company LLC Earns Spot in Prestigious CTIP Pediatric Healthcare Innovation Portfolio

April 11, 2024

Source:The Insides Company LLC

On:April 11, 2024

The Insides Company LLC announces its acceptance into the United States Consortium for Technology & Innovation in Pediatrics (CTIP) Portfolio, marking a significant leap in pediatric healthcare technology. This collaboration underscores the company’s commitment to pioneering healthcare solutions for neonatal and pediatric patients.

Rob Davidson, CTO of The Insides Company shares, “Joining the CTIP Portfolio amplifies our ability to advance clinical nutrition for pediatric patients with intestinal failure through enhanced access to critical resources and expertise.”

Established in 2011, CTIP is a leader in pediatric healthcare innovation, supporting the development and commercialization of medical devices for children through collaboration among industry experts.

The partnership focuses on accelerating The Insides Company’s second product of its chyme reinfusion technology platform, The Insides Neo, leveraging CTIP’s comprehensive resources for regulatory, market, and product development support.

Juan Espinoza, MD, FAAP, Director of CTIP, highlights the potential impact: “We are excited about [The Insides Neo], [the] team, and the potential impact it will have on the health and well-being of children everywhere. We look forward to working with [The Insides Company]”.

The alliance with CTIP positions The Insides Company for ground-breaking contributions to pediatric medical care, driving forward the development and accessibility of innovative medical devices.

About The Insides Company

The Insides Company LLC is a leading provider of automated chyme reinfusion therapies for the therapeutic treatment of adult, neonatal and pediatric intestinal failure that has resulted from either a high-output enterocutaneous fistula or enterostomy.

About CTIP

CTIP, based at Lurie Children’s Hospital and Children's Hospital Los Angeles, accelerates the commercialization and clinical application of pediatric medical device technology, promoting advancements in pediatric healthcare.


The Insides Company LLC

Garth Sutherland, CEO


Juan Espinoza, MD, FAAP Director, The Consortium for Technology & Innovation in Pediatrics

Choose Your Language

Selecting language below will change the language for